Skip to content
Catalyst

PapersPMID:18611150

Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.

Journal of alternative and complementary medicine (New York, N.Y.)2008The record ↗

  1. Finding, very limited evidenceraisesRey Auditory Verbal Learning Test delayed recall score

What moved

1 findingHow to read these marks →
  • “Controlling for baseline cognitive deficit using the Blessed Orientation-Memory-Concentration test, Bacopa participants had enhanced AVLT delayed word recall memory scores relative to placebo.”
    Study
    RCT
    Duration
    3 months
    Dose studied
    300 mg/day
    Population
    Healthy elderly participants aged 65 or older (mean age 73.5 years), without clinical signs of dementia

Study record

Design
randomised controlled trial
Species
human
Population
Community-dwelling adults aged 65 or older (mean age 73.5 years) without clinical signs of dementia, recruited in Portland, Oregon
Participants
54
Comparator
placebo
Duration
84 days
Endpoints measured
10